Literature DB >> 31266905

Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: A prospective study.

Chaoran Ma1, M Edip Gurol1, Zhe Huang1, Alice H Lichtenstein1, Xiuyan Wang1, Yuzhen Wang1, Samantha Neumann1, Shouling Wu2, Xiang Gao2.   

Abstract

OBJECTIVE: To prospectively examine the association between low-density lipoprotein (LDL) cholesterol (LDL-C) concentrations and intracerebral hemorrhage (ICH) risk.
METHODS: The current cohort study included 96,043 participants (mean age 51.3 years) who were free of stroke, myocardial infarction, and cancer at baseline (2006). Serum LDL-C concentrations were assessed in 2006, 2008, 2010, and 2012. Cumulative average LDL-C concentrations were calculated from all available LDL-C data during that period. Incident ICH was confirmed by review of medical records.
RESULTS: We identified 753 incident ICH cases during 9 years of follow-up. The ICH risk was similar among participants with LDL concentrations of 70 to 99 mg/dL and those with LDL-C concentrations ≥100 mg/dL. In contrast, participants with LDL-C concentrations <70 mg/dL had a significantly higher risk of developing ICH than those with LDL-C concentrations of 70 to 99 mg/dL; adjusted hazard ratios were 1.65 (95% confidence interval [CI] 1.32-2.05) for LDL-C concentrations of 50 to 69 mg/dL and 2.69 (95% CI 2.03-3.57) for LDL-C concentrations <50 mg/dL.
CONCLUSIONS: We observed a significant association between lower LDL-C and higher risk of ICH when LDL-C was <70 mg/dL, and the association became nonsignificant when LDL-C ≥70 mg/dL. These data can help determination of the ideal LDL range in patients who are at increased risk of both atherosclerotic disease and hemorrhagic stroke and guide planning of future lipid-lowering studies.
© 2019 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31266905      PMCID: PMC6693427          DOI: 10.1212/WNL.0000000000007853

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  47 in total

1.  Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program.

Authors:  K Yano; D M Reed; C J MacLean
Journal:  Stroke       Date:  1989-11       Impact factor: 7.914

2.  Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050.

Authors:  K M Venkat Narayan; James P Boyle; Linda S Geiss; Jinan B Saaddine; Theodore J Thompson
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

3.  What is the association of lipid levels and incident stroke?

Authors:  Stephen P Glasser; Aleena Mosher; George Howard; Maciej Banach
Journal:  Int J Cardiol       Date:  2016-06-23       Impact factor: 4.164

4.  Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT).

Authors:  Noriaki Nakaya; Toru Kita; Hiroshi Mabuchi; Masunori Matsuzaki; Yuji Matsuzawa; Shinichi Oikawa; Yasushi Saito; Jun Sasaki; Kazuaki Shimamoto; Hiroshige Itakura
Journal:  Circ J       Date:  2005-09       Impact factor: 2.993

5.  Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis.

Authors:  Marc S Sabatine; Stephen D Wiviott; KyungAh Im; Sabina A Murphy; Robert P Giugliano
Journal:  JAMA Cardiol       Date:  2018-09-01       Impact factor: 14.676

6.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Authors:  Steven E Nissen; Stephen J Nicholls; Ilke Sipahi; Peter Libby; Joel S Raichlen; Christie M Ballantyne; Jean Davignon; Raimund Erbel; Jean Charles Fruchart; Jean-Claude Tardif; Paul Schoenhagen; Tim Crowe; Valerie Cain; Kathy Wolski; Marlene Goormastic; E Murat Tuzcu
Journal:  JAMA       Date:  2006-03-13       Impact factor: 56.272

Review 7.  Prevention of stroke: a strategic global imperative.

Authors:  Valery L Feigin; Bo Norrving; Mary G George; Jennifer L Foltz; Gregory A Roth; George A Mensah
Journal:  Nat Rev Neurol       Date:  2016-07-22       Impact factor: 42.937

8.  Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.

Authors:  Robert P Giugliano; Terje R Pedersen; Jeong-Gun Park; Gaetano M De Ferrari; Zbigniew A Gaciong; Richard Ceska; Kalman Toth; Ioanna Gouni-Berthold; Jose Lopez-Miranda; François Schiele; François Mach; Brian R Ott; Estella Kanevsky; Armando Lira Pineda; Ransi Somaratne; Scott M Wasserman; Anthony C Keech; Peter S Sever; Marc S Sabatine
Journal:  Lancet       Date:  2017-08-28       Impact factor: 79.321

9.  Blood Pressure Trajectories and the Risk of Intracerebral Hemorrhage and Cerebral Infarction: A Prospective Study.

Authors:  Weijuan Li; Cheng Jin; Anand Vaidya; Yuntao Wu; Kathryn Rexrode; Xiaoming Zheng; Mahmut E Gurol; Chaoran Ma; Shouling Wu; Xiang Gao
Journal:  Hypertension       Date:  2017-07-17       Impact factor: 10.190

10.  Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study.

Authors:  Valery L Feigin; Rita V Krishnamurthi; Priya Parmar; Bo Norrving; George A Mensah; Derrick A Bennett; Suzanne Barker-Collo; Andrew E Moran; Ralph L Sacco; Thomas Truelsen; Stephen Davis; Jeyaraj Durai Pandian; Mohsen Naghavi; Mohammad H Forouzanfar; Grant Nguyen; Catherine O Johnson; Theo Vos; Atte Meretoja; Christopher J L Murray; Gregory A Roth
Journal:  Neuroepidemiology       Date:  2015-10-28       Impact factor: 3.282

View more
  30 in total

1.  In utero exposure to the Great Chinese Famine and risk of intracerebral hemorrhage in midlife.

Authors:  Yun Li; Yanping Li; M Edip Gurol; Yesong Liu; Peng Yang; Jihong Shi; Sheng Zhuang; Michele R Forman; Shouling Wu; Xiang Gao
Journal:  Neurology       Date:  2020-04-10       Impact factor: 9.910

2.  Low-Density Lipoprotein Cholesterol and Risk of Hemorrhagic Stroke: a Systematic Review and Dose-Response Meta-analysis of Prospective Studies.

Authors:  Chaoran Ma; Muzi Na; Samantha Neumann; Xiang Gao
Journal:  Curr Atheroscler Rep       Date:  2019-11-20       Impact factor: 5.113

Review 3.  Stroke Prevention After Intracerebral Hemorrhage: Where Are We Now?

Authors:  Hae Young Baang; Kevin N Sheth
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 2.931

Review 4.  Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.

Authors:  Richa Tyagi; Bhupesh Vaidya; Shyam Sunder Sharma
Journal:  Pharmacol Rep       Date:  2022-09-23       Impact factor: 3.919

Review 5.  Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage.

Authors:  Ashkan Shoamanesh; Magdy Selim
Journal:  Stroke       Date:  2022-06-06       Impact factor: 10.170

Review 6.  Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988).

Authors:  Maciej Banach; Niloofar Shekoohi; Dimitri P Mikhailidis; Gregory Y H Lip; Adrian V Hernandez; Mohsen Mazidi
Journal:  Arch Med Sci       Date:  2022-01-19       Impact factor: 3.707

7.  Various effects of nutritional status on clinical outcomes after intracerebral hemorrhage.

Authors:  Yuji Shiga; Tomohisa Nezu; Ryo Shimomura; Kota Sato; Takahiro Himeno; Yuka Terasawa; Shiro Aoki; Naohisa Hosomi; Tatsuo Kohriyama; Hirofumi Maruyama
Journal:  Intern Emerg Med       Date:  2021-12-01       Impact factor: 5.472

Review 8.  A practical approach to the management of cerebral amyloid angiopathy.

Authors:  Mariel G Kozberg; Valentina Perosa; M Edip Gurol; Susanne J van Veluw
Journal:  Int J Stroke       Date:  2020-11-29       Impact factor: 6.948

9.  Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey.

Authors:  Philip J Barter; Shizuya Yamashita; Ulrich Laufs; Alvaro J Ruiz; Rody Sy; Mark David G Fang; Emanuela Folco; Peter Libby; Yuji Matsuzawa; Raul D Santos
Journal:  Lipids Health Dis       Date:  2020-06-10       Impact factor: 3.876

10.  The impact of the cumulative burden of LDL-c and hs-CRP on cardiovascular risk: a prospective, population-based study.

Authors:  Jinglin Mo; Zimo Chen; Jie Xu; Anxin Wang; Xia Meng; Xingquan Zhao; Hao Li; Shouling Wu; Yongjun Wang
Journal:  Aging (Albany NY)       Date:  2020-06-16       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.